Companies: 10,795·Total market cap: $144.5T
4DMedical Limited

4DMedical Limited

FDMDFOTCHealthcare● Active
$2.66
+$0.00(+0.00%)
Market Cap$1.6B
P/E Ratio
52W High$5
52W Low$0.16245
Overview

4DMedical Limited (FDMDF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

FDMDF · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$6.9M -77.5% vs prior year
FY · as of Jun 30, 2025 · Reported in AUD
Cash & Cash Equiv. (CCE)
$6.9M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-77.5%
vs prior fiscal year
Latest Quarter
$56.7M
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in AUD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$6.9MCash on Hand
Total Debt$4.3MTotal Debt
Net Cash / Net Debt+$2.6MNet Cash Position
Cash vs Debt Ratio
Cash 61%Debt 39%

4DMedical Limited has a net cash position of $2.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$6.9M$4.3M = +$2.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
FDMDF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$6.9M-77.5%
Jun 30, 2024$30.6M-56.0%
Jun 30, 2023$69.6M+36.1%
Jun 30, 2022$51.1M-36.8%
Jun 30, 2021$80.9M+859.5%
FDMDF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
4DMedical Limited
4DMedical LimitedYOU
FDMDF
$6.9M0.4%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

4DMedical Limited (FDMDF) cash on hand as of June 30, 2025 is $6.9M, comprising $6.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as 4DMedical Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as 4DMedical Limited cash reserves or cash position.

4DMedical Limited annual cash on hand history shows decreased -77.5% in 2025: decreased -77.5% in 2025. 4DMedical Limited cash reserves in 2025 reflect the company's capital allocation strategy.

4DMedical Limited carries total debt of $4.3M against cash of $6.9M, resulting in a net cash position of +$2.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

FDMDF cash on hand · 5 questions

As of June 30, 2025, 4DMedical Limited (FDMDF) has $6,878,735 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $6,878,735 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $56,739,557. Data sourced from the annual 10-K filing via FMP.

FDMDF cash on handFDMDF cash reservesFDMDF cash 2025how much cash does FDMDF have

Source: FMP /balance-sheet-statement · US GAAP · 4DMedical Limited · 4DMedical Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025